190 related articles for article (PubMed ID: 18339881)
21. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA
Misawa A; Kondo Y; Takei H; Takizawa T
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33514011
[TBL] [Abstract][Full Text] [Related]
23. The HOXC6 homeodomain-containing proteins.
Chariot A; Gielen J
Int J Biochem Cell Biol; 1998 Jun; 30(6):651-5. PubMed ID: 9695021
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.
Scharer CD; McCabe CD; Ali-Seyed M; Berger MF; Bulyk ML; Moreno CS
Cancer Res; 2009 Jan; 69(2):709-17. PubMed ID: 19147588
[TBL] [Abstract][Full Text] [Related]
25. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.
Yu G; Lee YC; Cheng CJ; Wu CF; Song JH; Gallick GE; Yu-Lee LY; Kuang J; Lin SH
Mol Cancer Res; 2015 Feb; 13(2):348-57. PubMed ID: 25189355
[TBL] [Abstract][Full Text] [Related]
26. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells.
Kim KJ; Moon SM; Kim SA; Kang KW; Yoon JH; Ahn SG
Oncogene; 2013 Jul; 32(28):3339-49. PubMed ID: 22907429
[TBL] [Abstract][Full Text] [Related]
28. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
Front Immunol; 2021; 12():781221. PubMed ID: 34950145
[TBL] [Abstract][Full Text] [Related]
29. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
Gu K; Zhang L; Jin T; Rutherford RB
Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
[TBL] [Abstract][Full Text] [Related]
31. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
32. Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
Lin DL; Tarnowski CP; Zhang J; Dai J; Rohn E; Patel AH; Morris MD; Keller ET
Prostate; 2001 May; 47(3):212-21. PubMed ID: 11351351
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer.
Tamada H; Kitazawa R; Gohji K; Kitazawa S
J Bone Miner Res; 2001 Mar; 16(3):487-96. PubMed ID: 11277266
[TBL] [Abstract][Full Text] [Related]
34. Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Schlicht M; Matysiak B; Brodzeller T; Wen X; Liu H; Zhou G; Dhir R; Hessner MJ; Tonellato P; Suckow M; Pollard M; Datta MW
BMC Genomics; 2004 Aug; 5(1):58. PubMed ID: 15318950
[TBL] [Abstract][Full Text] [Related]
35. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
[TBL] [Abstract][Full Text] [Related]
36. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells.
Harris SE; Harris MA; Mahy P; Wozney J; Feng JQ; Mundy GR
Prostate; 1994 Apr; 24(4):204-11. PubMed ID: 8146069
[TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
Yang S; Lim M; Pham LK; Kendall SE; Reddi AH; Altieri DC; Roy-Burman P
Cancer Res; 2006 Apr; 66(8):4285-90. PubMed ID: 16618753
[TBL] [Abstract][Full Text] [Related]
38. Bone morphogenic factor gene dosage abnormalities in prostatic intraepithelial neoplasia and prostate cancer.
Doak SH; Jenkins SA; Hurle RA; Varma M; Hawizy A; Kynaston HG; Parry JM
Cancer Genet Cytogenet; 2007 Jul; 176(2):161-5. PubMed ID: 17656261
[TBL] [Abstract][Full Text] [Related]
39. Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice.
Garcia-Gasca A; Spyropoulos DD
Dev Dyn; 2000 Oct; 219(2):261-76. PubMed ID: 11002345
[TBL] [Abstract][Full Text] [Related]
40. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
